1. Activities of the IHE-J cardiology IHE-J Cardiology planning Committee Dr. Kohro, M.D., Ph.D (Tokyo University) Dr. Takeda, M.D.., Ph.D (Tokyo Metropolitan Geriatric And Institute of Gerontology) IHE-J Cardiology Technical Committee Takeshi. Ozeki

2. IHE-J Organization Board Committee Operation Committee Technical CommitteePlanning Committee Radiology Domain Radiation Therapy (Oncology) Domain Cardiology Domain Clinical Lab. Domain Pathology Lab. Domain Endoscopy Domain Optometry Domain Prevalence PromotionCommittee RFP Committee International CommitteeTest and Tool Committee

3. IHE-J’s Funding Structure From the IHE-J membership fees (S, A, B members) – Companies – Professional Society Sponsor (JIRA, JAHISS, JSRT, JSR, etc) Supporter (JCS, etc) Connectathon fees Grant From the Ministry of Health, warfare, and labor – Japanization of the “gazelle” tool

4. IHE-J-Cardiology Planning Committee: – Chairman: Dr. Nagai, M.D., Ph.D (Tokyo Univ.) – Organizing director: Dr. Takehana, M.D., Ph.D (Kansai Med Univ.) Technical Committee: – Co-Chairman: M. Hirai (Nihon Kohden) – Co-Chairman: T. Ozeki (Toshiba) Sub-Working Committee – Data Handling: Dr. Kohro, M.D., Ph.D / M. Oe (Toshiba) – IVI: Dr. Takeda, M.D., Ph.D / H. Yagami (Terumo) – Waveform data: Dr. Sato, M.D., Ph.D / Koyama (Nihon Koden) – Stress : Dr. Takehana, M.D., Ph.D / Kobayashi (Fukuda Denshi) – Connectathon & Demo: Nakano (Toshiba)/ Yagami (Terumo)

5. Activity I Connectathon 2011 (November 7-11, 2011) – Cath – Echo – ECG (Retrieve for Display using MFER (ISO)) – Stress (Echo) – ED (Echo) – IVI (Trial Implementation) Survey (Questionnaire) for the Cath Report Pre-Connectathon (trial use of Japanized “Gazelle”) – Exchange information with INRIA Demo/Presentation at the JCS 2012 in Fukuoka

6. Activity II (IVI Profile) Why we need to extract from the Cath Workflow: (From the Introduction of the White paper) The intravascular imaging (IVI) includes the intravascular ultrasound (IVUS), the optical coherence tomography (OCT), etc. The coronary angiogram (CAG) injects the contrast media into the intravascular cavity and obtains a silhouette image. Therefore, there is a limit in evaluation of the vessel wall. On the contrary, IVI evaluates the vessel wall and the intravascular cavity from inside, and obtain information about the pathological change, calcification, etc. IVI is also useful to decide the treatment policy before performing the percutaneous coronary intervention (PCI). Because of this context, there are more IVI cases in Japan than in Europe and the United States. At present, IVI is designated merely as one of the modalities belonging to the cardiac catheterization workflow integrated profile (CATH). Such designation makes it difficult to manage IVI in medical facilities, probably preventing the future development of studies and devices. Integrating the Healthcare Enterprise (IHE) is an initiative designed to stimulate the integration of the information systems that support modern healthcare institutions. Its fundamental objective is to ensure that in the care of patients all required information for medical decisions is both correct and available to healthcare professionals. Therefore, it is necessary to establish the intravascular imaging (IVI) study workflow integrated profile.